
Strengthening Vaccine Production and Access to Routine Immunizations in Sub-Saharan Africa | The CommonHealth Live!
Two years since the launch of the African Vaccine Manufacturing Accelerator (AVMA), a financial mechanism that invests in commercially viable manufacturing efforts on the continent, what progress has been made in the effort to produce 800 million vaccines in Africa by 2035? Where are there opportunities for strengthening access to routine immunizations for vulnerable populations, including the 6.7 million zero-dose children in the region, along with those living in fragile and conflict-affected areas? And how can the AVMA, which was developed in response to the region’s challenges in securing…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.